
Bulgaria-founded clinical development firm Clarenta invests in France's L2D
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPblhMZG5lMTNjSHhrMEtnbzV5ekZCZU1pVElxbVI0eHV0dkVlZFJuX24td2gxZVVrZjl6SGpMcGs5blZkUVNVdDBVaG01aGpFMFVzU2owLXZRS2htUk1ZWW4zUUprSEpTM2ItYkF5ZnNPLVJrVXRSVk12RE44Z19Wel9Ram1oeEx0b2hDMXFtR2JncndyUUFwNE9od0xhN3pyXzNNTFhhVHN6MVk?oc=5" target="_blank">Bulgaria-founded clinical development firm Clarenta invests in France's L2D</a>&nbsp;&nbsp;<font color="#6f6f6f">SeeNews</font>
